Conferences
#ESHCML2020

ESH-iCMLf 22nd Annual John Goldman E-Conference on
Chronic Myeloid Leukemia: Biology and Therapy

#ESHCML2020
Translational
October 1-4, 2020
-
E-Conference

Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause

‍

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, François-Xavier Mahon, Danilo Perrotti, Jerry Radich, Delphine Réa

‍

Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

‍

ESH-iCMLf 22nd Annual John Goldman E-Conference on
Chronic Myeloid Leukemia: Biology and Therapy

Information

‍

ABOUT THE CONFERENCE:

Speakers at this meeting will present the newest and often unpublished data relating to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells, approaches to cure and treatment free remission.

‍

SCIENTIFIC TOPICS:

• Stem Cells and the microenvironment
• Molecular biology and new targets
• Proteomics and Secretomics
• Artificial Intelligence and Machine Learning
• Mechanisms of resistance and disease progression
• Biomarkers
• Immunology and Inflammation
• Therapeutic interventions
• Immunotherapy
• Treatment free remission
• Safety and patient reported outcomes
• Clinical trial design
• The new ELN recommendations
• New drugs in development

‍

‍

Program

Read the final program!

CLICK HERE
ON-DEMAND CONTENT AVAILABLE
CLICK HERE

Corporate partners

With the support of*:

‍

Emerald E-Conference Partners
*******

‍

Ruby E-Conference Partner
*******

‍

‍*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

‍

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences